Efficacy and Safety of Dapagliflozin As Adjunct Therapy in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea. ajm 2026, 9 (2), 201-205. https://doi.org/10.48165/ajm.2026.9.02.34.